Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the "Meeting") shareholders voting in person or by proxy held in total 265,763,587 common shares of the Company, representing 70.76% of the total number of common shares of the Company outstanding.

Each of the directors listed as a nominee in the Company's proxy statement dated April 29, 2022 (the "Proxy Statement") was elected as a director of the Company, with each director receiving in excess of 91.6% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

Name of Director Number of Shares
Voted For
Percentage of Shares
Voted For
Number of Shares
Withheld from
Percentage of Shares
Withheld from
Jason Adler 191,194,336 92.14% 16,307,599 7.85%
Kendrick Ashton, Jr. 205,094,214 98.83% 2,407,721 1.16%
Jody Begley 193,224,325 93.11% 14,277,610 6.88%
Murray Garnick 193,608,672 93.30% 13,893,263 6.69%
Michael Gorenstein 195,779,852 94.35% 11,722,083 5.64%
Heather Newman 193,681,397 93.33% 13,820,538 6.66%
James Rudyk 190,147,187 91.63% 17,354,748 8.36%

Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company's named executive officers, with 95.02% of votes cast in favor of such resolution, and approved the re-appointment of KPMG LLP as the Company's independent auditors.

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company's SEDAR profile at and the Company's Form 8-K filed on EDGAR at

About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach ® , PEACE NATURALS ® , Lord Jones ® , Happy Dance ® and PEACE+™. For more information about Cronos and its brands, please visit:

Forward-looking Statements
This press release may contain information that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws (collectively, "Forward-looking Statements"). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the Company's intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and Quarterly Report on Form 10-Q for the period ended March 31, 2022, both of which have been filed on SEDAR and EDGAR and can be accessed at and, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Contact
Shayne Laidlaw
Tel: (416) 504-0004

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
Cannabis Investing

Ongoing Growth in North America’s Cannabis Space

An article curated by Bazinga highlighted the cannabis market trends from last week. Even though last week was short, the cannabis sector was a busy. The article went on to highlight a number of the cannabis companies looking preparing for their IPOs, among other cannabis related news.

The article went on to highlight the Flowr Corporation as one of numerous companies looking to go public by the end of the year. Flowr’s management team is responsible for the creation and success of MedReleaf, an R&D focused company in the medical cannabis space. In preparation for its RTO in Canada, the company has raised $36 million in financing.

Keep reading...Show less
cannabis buds in jar

How to Invest in Cannabis (Updated 2023)

Cannabis legalization in countries around the world has helped kickstart a brand-new investment landscape. As the global cannabis market matures, are you thinking about investing in cannabis companies?

A wide spectrum of cannabis stocks, from small to large cap, have made their mark on the industry as recreational and medical markets emerge and develop across the world. Increased attention from established industries, including pharmaceutical and beverage companies, has also helped make cannabis mainstream.

What’s to come is anyone’s guess, but it seems this burgeoning industry still has room to grow, with diverse nations beginning to move forward with plans for bringing cannabis to the market on some level.

Keep reading...Show less

Goodness Growth Holdings Announces Departure of Chief Financial Officer

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), today announced that the Company's Chief Financial Officer, John Heller, will depart the Company effective September 30 to accept a new external opportunity. Interim Chief Executive Officer Josh Rosen will assume the additional role of Interim Chief Financial Officer.

Executive Chairman Dr. Kyle Kingsley commented, "We are sad to see John leave, but are grateful for his leadership and the contributions he made during his three-year tenure. John has helped us establish an excellent finance and accounting team which maintains exemplary financial controls and reporting practices. On behalf of our entire board and leadership team, we thank John and wish him well in his future endeavors."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Cannabis Dispensary in Evans, Georgia

Company celebrates grand opening and expands access to low-THC products for patients in the Augusta metropolitan area

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States announced the grand opening of a new medical cannabis dispensary located at 4218 Washington Road in Evans, GA.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Announces Purchase of 8% Senior Secured Notes due 2026

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the open market purchase of 57,000 of its USD $1,000 face value senior secured notes due October 6, 2026 (the "Notes") for a purchase price of USD $47.6 million which represents a 16.5% discount to par, plus accrued interest. The Notes trade on the Canadian Securities Exchange under the symbol "TRUL.NT.U".

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

This press release is for information purposes only and is not an offer to purchase, a solicitation of an offer to sell the Notes or any other securities of the Company.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210

Media Contact
Phil Buck , Corporate Communications Manager
+1 (406) 370-6226

Cision View original content to download multimedia:

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia:

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos launches leading medical brand PEACE NATURALS® in Germany

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group ("Cansativa"), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis industry. Cansativa has a network of approximately 2,000 pharmacies domestically; they currently supply around 300,000 patients in Germany's medical market.

"Re-entering the German market, which has about 83 million people, is a significant milestone for Cronos and we look forward to expanding our reach and brand awareness in Germany with the help of Cansativa," said Mike Gorenstein, Chairman, President, and CEO, Cronos. "We intend to establish our PEACE NATURALS ® brand as a top medical brand, similar to the brand's reputation in Israel. We will continue to push forward on new market growth opportunities and expand our portfolio of borderless products."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Cannabis Dispensary in Pace, Florida

Company celebrates grand opening and expands medical cannabis access to patients in Escambia and Santa Rosa counties

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical dispensary located at 5037 Hwy 90, Pace, Fla. The new location will be open 9 a.m. 8:30 p.m. Monday through Saturday and 11 a.m. 8 p.m. on Sundays .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News